According to the World Health Organization, one in every six deaths worldwide is caused by cancer. This was reported by Zamin.uz.
Therefore, large funds are allocated to major projects aimed at deeply studying this disease, identifying its causes, and early diagnosis. According to "The Lancet Oncology," from 2016 to 2023, a total of 108,000 grants amounting to 51.4 billion euros were awarded worldwide for cancer research.
These funds include contributions from government and charitable organizations, but expenses from the private sector are not taken into account. Among the countries that allocated the most funds, the United States leads, spending 57 percent of the global funds, that is 25.2 billion euros.
European Union countries rank second with 16.8 percent, contributing 7.4 billion euros. The United Kingdom accounts for 11.1 percent (4.9 billion euros), Japan 3.6 percent (1.6 billion euros), Australia 2.9 percent (1.3 billion euros), and Canada and China each allocated 2.6 percent.
The United States remains the only country allocating the largest funds for cancer research. At the same time, European countries also contribute significantly by allocating billions of euros in this field.
However, poor countries lag behind in research due to a lack of financial resources. The total amount they spend is 48.4 million euros, which is very low compared to other countries.
Seventy-six percent of the allocated funds are directed towards laboratory research. In particular, studying common types such as breast cancer and blood cancer, as well as financing clinical trials, are priority areas.
Experts emphasize that such large investments play an important role not only in developing new drugs but also in early detection and prevention of the disease. This serves to improve global health.
